IL17A and pneumococcal infection: The necessity for this CD4+, Th17-like response is supported by a decrease in incidence and severity of pneumococcal infections with age, independent of serum levels of anti-pneumococcal antibody [82], as well as the increased susceptibility to pulmonary infection in humans with deficient IL-17 signaling [83,84].